Pharmaceutical News

RSS

EMA's CHMP gives positive opinion for PTC Therapeutics' Translarna

PTC Therapeutics, Inc. today announced that following its request for re-examination, the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion regarding the company's application for a conditional marketing authorization of Translarna (ataluren) for the treatment of nonsense mutation Duchenne muscular dystrophy (nmDMD) in ambulatory patients aged five years and older.

23 May 2014

Analysis of key cellular protein demonstrates the effectiveness of Taxol anti-cancer drug

A pathway to the design of even more effective versions of the powerful anti-cancer drug Taxol has been opened with the most detailed look ever at the assembly and disassembly of microtubules, tiny fibers of tubulin protein that form the cytoskeletons of living cells and play a crucial role in mitosis.

23 May 2014

Presentation at NMS 2014 highlights growing dangers of non-steroidal anti-inflammatory drugs

A presentation at this week’s National Medicines Symposium in Brisbane has highlighted the dangers of people taking common medicines such as non-steroidal anti-inflammatories (NSAIDs) without thinking about the potential risks or harms.

23 May 2014

European Commission grants Marketing Authorization for empagliflozin for treatment of type 2 diabetes

The European Commission has granted Marketing Authorisation for empagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor from Boehringer Ingelheim and Eli Lilly and Company.

23 May 2014

Growing resistance to antibiotics demands a coordinated global response, say experts

Growing resistance to antibiotics and other drugs demands a coordinated global response on the same scale as efforts to address climate change, experts say.

23 May 2014

Study: Children born with HIV more likely to develop resistance to antiretroviral drugs than adults

Children born with HIV are far more likely to develop resistance to antiretroviral drugs than adults, according to a new Tulane University School of Medicine study.

23 May 2014

New database allows researchers to match old drugs for new diseases

There are thousands of drugs that silence many thousands of cancer-causing genetic abnormalities. Some of these drugs are in use now, but many of these drugs are sitting on shelves or could be used beyond the disease for which they were originally approved.

23 May 2014

Pain receptors may hold key to treating obesity, diabetes and improving metabolic health

Blocking a pain receptor in mice not only extends their lifespan, it also gives them a more youthful metabolism, including an improved insulin response that allows them to deal better with high blood sugar.

23 May 2014

EMA grants Advanced Therapy Medicinal Product classification for TxCell's Col-Treg

TxCell SA, a biotechnology company developing innovative, personalized cell-based immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and autoimmune diseases, announces today that Col-Treg, its second therapeutic candidate from its ASTrIA platform, has been granted Advanced Therapy Medicinal Product (ATMP) classification by the Committee for Advanced Therapies (CAT) of the European Medicines Agency.

22 May 2014

IBM collaborates with Zambian Ministry of Health to provide life saving drugs to citizens

IBM today announced a collaboration with the Zambian Ministry of Health to provide citizens with improved access to 200 life saving drugs.

22 May 2014

Eisai launches new class of epilepsy treatment Fycompa in France

Fycompa (perampanel), the first in an entirely new class of treatment for partial onset seizures (the most common form of epilepsy), has today received reimbursement approval from the Comité Economique des Produits de Santé.

22 May 2014

Drugs that boost protein's production in neurons could help ward off Alzheimer's disease

In surprise findings, scientists at The Scripps Research Institute (TSRI) have discovered that a protein with a propensity to form harmful aggregates in the body when produced in the liver protects against Alzheimer's disease aggregates when it is produced in the brain.

22 May 2014

AHIP hits hard on cost issue, using hepatitis C drug as example

The leading U.S. health insurance trade group on Tuesday hit out at the extremely high cost of new specialty medicines, accusing drugmakers of taking advantage of the insurance system by pricing products at unsustainable levels.

22 May 2014

Researchers use computer simulations to identify drugs most likely to kill cancer cells

Researchers at University of California, San Diego School of Medicine and Moores Cancer Center have used computer simulations of cancer cells - cancer avatars - to identify drugs most likely to kill cancer cells isolated from patients' brain tumors.

22 May 2014

VTT scientists discover unknown Cent-1 molecule that kills cancer cells

A team of research scientists from VTT Technical Research Centre of Finland, the University of Turku and the University of Eastern Finland has discovered a previously unknown Cent-1 molecule that kills cancer cells.

22 May 2014

Dolutegravir drug offers added benefit in HIV patients

Dolutegravir has been approved since January 2014 in combination with other antiretroviral drugs for the treatment of human immunodeficiency virus (HIV) infected adults and adolescents above 12 years of age.

22 May 2014

School-based influenza vaccine programs limited by low rates of reimbursement

School-based influenza vaccine programs have the potential to reach many children at affordable costs and with parental support, but these programs are limited by low rates of reimbursement from third-party payers, according to recently published study results by researchers from the University of Colorado School of Medicine.

21 May 2014

Combination of metformin and rapamycin shows potential in treating aging and related diseases

A proven approach to slow the aging process is dietary restriction, but new research in the Linus Pauling Institute at Oregon State University helps explain the action of a drug that appears to mimic that process - rapamycin.

21 May 2014

Serious complications due to anesthesia during childbirth are very rare

Expectant mothers concerned about receiving an epidural, spinal or general anesthesia during childbirth can breathe a little easier. According to a study published in the June issue of Anesthesiology, the official medical journal of the American Society of Anesthesiologists, serious complications due to anesthesia during childbirth are very rare, occurring in one out of every 3,000 deliveries.

21 May 2014

NIDA guides target both teens and parents with up-to-date science-based facts on marijuana

Two updated booklets about marijuana for teens and their parents will help families sort out marijuana myths from science-based facts. The revamped tools come from the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health.

21 May 2014

Pharmaceutical News

EMA's CHMP gives positive opinion for PTC Therapeutics' Translarna

Analysis of key cellular protein demonstrates the effectiveness of Taxol anti-cancer drug

Presentation at NMS 2014 highlights growing dangers of non-steroidal anti-inflammatory drugs

European Commission grants Marketing Authorization for empagliflozin for treatment of type 2 diabetes

Growing resistance to antibiotics demands a coordinated global response, say experts

Study: Children born with HIV more likely to develop resistance to antiretroviral drugs than adults

New database allows researchers to match old drugs for new diseases

Pain receptors may hold key to treating obesity, diabetes and improving metabolic health

EMA grants Advanced Therapy Medicinal Product classification for TxCell's Col-Treg

IBM collaborates with Zambian Ministry of Health to provide life saving drugs to citizens

Eisai launches new class of epilepsy treatment Fycompa in France

Drugs that boost protein's production in neurons could help ward off Alzheimer's disease

AHIP hits hard on cost issue, using hepatitis C drug as example

Researchers use computer simulations to identify drugs most likely to kill cancer cells

VTT scientists discover unknown Cent-1 molecule that kills cancer cells

Dolutegravir drug offers added benefit in HIV patients

School-based influenza vaccine programs limited by low rates of reimbursement

Combination of metformin and rapamycin shows potential in treating aging and related diseases

Serious complications due to anesthesia during childbirth are very rare

NIDA guides target both teens and parents with up-to-date science-based facts on marijuana

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News